跳至主要内容
临床试验/EUCTR2014-004784-20-ES
EUCTR2014-004784-20-ES进行中(未招募)不适用

Subcutaneous progesterone ( Prolutex ) versus vaginal progesterone capsules (Progeffik) for endometrial preparation in fresh donated oocyte recipients: A prospective, randomized, single-blind, pilot trial.

Instituto Bernabeu0 个研究点开始时间: 2014年12月16日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Female age between 18 and 49 years (inclusive)
  • Women who want pregnancy
  • Endometrial thickness greater than 7 mm on the randomization of the patient is made to a group of progesterone
  • more than 6 oocytes retrieved from the donor woman
  • Patient scheduled for fresh embryo transfer on day +5 embryo culture
  • BMI greater than 30 kg / m2
  • Infertility justify treatment with donor oocytes Women
  • Males no known alterations in karyotype
  • Semen ejaculation from either the partner or from bank
  • Uterus able to support embryo implantation and pregnancy
  • Absence of pregnancy before starting the cycle of embryo transfer
  • Have consented in writing
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Important endocrine-metabolic Systemic diseases affecting pituitary, thyroid, adrenals, pancreas, liver or kidney
  • Seropositivity for HIV, HBV or HCV
  • Undiagnosed vaginal bleeding
  • Pregnancy, lactation or contraindication for pregnancy
  • Malformations of sexual organs incompatible with pregnancy
  • Known allergy to preparations of progesterone or its excipients
  • Current dependence on alcohol, drugs or psychotropic
  • Concurrent participation in another study
  • Concomitant medication that could interfere with study medication

研究者

发起方
Instituto Bernabeu

相似试验